You "...imagine that the IPO is not far out [for Dan Montano's company]...". Since Zhittya Genesis Medicine is also advancing FGF-1 on multiple avenues, do you think Zhittya would be a good biotech IPO? What do you know about Zhittya's IPO???
How would Zhittya Genesis Medicine's IPO affect CVBT?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.